licensing_iconLicensing

In addition to helping clients secure protection for their own intellectual property, BSKB represents companies looking to license intellectual property rights to others to expand markets for their goods and services or to obtain licenses from others for more freedom to sell a broader range of goods or services. BSKB also assists clients who look to cross-license intellectual property rights to create joint cooperation agreements with other companies or, as part of a more complex litigation scenario, to settle disputes with other companies.

BSKB provides legal opinions for both prospective licensors and licensees to ensure companies can move forward with licensing and acquisition plans with confidence in the value of the related intellectual property. BSKB also assists clients with an inventory and valuation of intellectual property rights and identifying and targeting potential licensing targets, as well as drafting simple to highly complex intellectual property licensing agreements.

 

Attorneys and Professionals

  • Richard Anderson

    D. Richard Anderson

    Partner

    View
  • Charles Gorenstein

    Charles Gorenstein

    Senior Counsel

    View
  • Hyuk Jung Kwon

    Hyuk Jung Kwon

    Associate

    View
  • Michael Mutter

    Michael K. Mutter

    Partner

    View
  • Jun Nakamara

    Jun (Atsushi) Nakamura

    Registered Patent Agent

    View
  • Whitney Remily

    Whitney Remily

    Of Counsel

    View

Related Articles

View All Articles

Related Presentations

View All Presentations

Recent News

  • April 12, 2021

    Patent Law Institute 2021: Critical Issues & Best Practices

    BSKB is proud to announce that Partners, Gerald Murphy and Chad Rink will presenting again at this year's Practising Law Institute (PLI), April 30, 2021 beginning at 9AM PT. Mr. Murphy and Mr. Rink will be discussing Chemical, Pharmaceutical and Biotech Updates Affecting Patent Prosecution.

  • February 26, 2021

    High Court Mulls Taking Up Diagnostic Patent Eligibility Fight

    Partner MaryAnne Armstrong was quoted in a Bloomberg Law article discussing Ariosa’s appeal to the Supreme Court of a Federal Circuit decision reviving Illumina Inc.'s fetal DNA test patents and what the outcome could mean for patent eligibility in the biotech industry.

View All News

Contact Us